3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
6
Leukemia, Myeloid, Acute
4
Uveal Melanoma
2
Lymphoma
2
Leukemia
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
Recurrence
1
Rectal Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Meningeal Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myeloid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Kidney Diseases
1
Gastrointestinal Neoplasms
1
Interventions
Nivolumab
7
cabozantinib
5
Specimen Handling
5
Ipilimumab
5
CTLA-4 Antigen
4
Magnetic Resonance Spectroscopy
2
sodium-iodide symporter
1
sitravatinib
1
lenvatinib
1
fludarabine
1
Zoledronic Acid
1
Tissue Banks
1
Radiotherapy
1
Radiopharmaceuticals
1
Pluvicto
1
Ibandronic Acid
1
Everolimus
1
Diphosphonates
1
Denosumab
1
Blood Specimen Collection
1
Biopsy
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Clear-cell metastatic renal cell carcinoma
×
Interleukin-2
×
90 days
×
Clear all
No trials found.